JAGX שווי כולל של נכסי החברה Jaguar Health Inc

The business stability of Jaguar Health, Inc. (JAGX) relies on exclusive ownership rights to Mytesi, which creates a patent shield, although the slow expansion of oncology therapy is constraining profits. Meanwhile, the company is troubled by debt, weak revenue dynamics, and the risk of delisting due to the issuance of new shares. This price chart demonstrates total assets at 59.39, highlighting its status as a manufacturer of unique botanical remedies for treating diarrhea in severely ill patients.

This indicator reflects the total resource volume of Jaguar Health, Inc. (JAGX), reverse-calculated via return on assets (ROA) to assess capital management efficiency under tight monetary policy. By analyzing total assets, an investor can discern the ability of Lisa Conte's management to flexibly transform the balance sheet structure, ensuring uninterrupted funding for R&D projects while maintaining the stability of the core business.